KATIE TANNER: Open Payments
NPI 1831604800 · HIGHLANDS RANCH, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,518 in 136 payments from 20 companies in 2025. Trend: 2023 $1,587 · 2024 $2,848 · 2025 $3,518
Food & beverage: $3,334Education: $184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $942 |
| GENZYME CORPORATION | 30 | $888 |
| CSL Behring | 12 | $228 |
| Genentech USA, Inc. | 13 | $214 |
| GlaxoSmithKline, LLC. | 11 | $187 |
| SANOFI-AVENTIS U.S. LLC | 2 | $184 |
| Regeneron Healthcare Solutions, Inc. | 8 | $147 |
| Novartis Pharmaceuticals Corporation | 6 | $125 |
| BioCryst US Sales Co., LLC | 5 | $109 |
| Organon LLC | 5 | $75 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Xolair, Andembry, TRELEGY ELLIPTA, ORLADEYO, BREZTRI.
Industry payments across CO — which companies pay providers there.
